Many therapeutic drugs are racemates; i.e. they are chiral molecules consisting of "left"-and "right-handed" enantiomers (stereoisomers that are mirror images of each other, and are non-superimposable). In some cases, both enan-tiomers of the drug contribute to some extent (or equally) to the therapeutic effect; in other cases they contribute not at all. The same is true for the adverse effects of racemate drugs: the adverse effects of a racemate drug can be greater-than, less-than, or equal to one or the other enantiomer. An unusual situation arises when a drug consists of "atropisomers", stereoisomers arising because of hindered rotation about a single chemical bond. We summarize the concept of atropisomerism, and give examples.
CITATION STYLE
Raffa, R. B., Pergolizzi, J. V., & Taylor, R. (2020). “Atropisomeric” Drugs: Basic Concept and Example of Application to Drug Development. Pharmacology & Pharmacy, 11(01), 1–8. https://doi.org/10.4236/pp.2020.111001
Mendeley helps you to discover research relevant for your work.